Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Low Urine Citrate: Kidney Stone Risk and Next Steps

カテゴリー
Articles

Kidney Stone Prevention Lab Interpretation 2026 Update Patient-Friendly A low citrate result is a modifiable kidney-stone risk factor, not a diagnosis on its own. The useful next step is to interpret it alongside urine volume, pH, calcium, sodium, oxalate, and your stone history. 📖 ~11 minutes 📅 September 20, 2026 📝 Published: September 20, 2026 🩺 Medically Reviewed: September 20, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI […]

High SHBG Causes: Reading Sex Hormone Results Correctly

カテゴリー
Articles

Hormone Health Lab Interpretation 2026 Update Patient-Friendly A high SHBG result usually reflects thyroid status, estrogen exposure, liver signaling, energy deficit, aging, or medicines—not a diagnosis on its own. The practical issue is whether it makes your available testosterone or estradiol lower than the total-hormone result suggests. 📖 ~11 minutes 📅 September 19, 2026 📝 Published: September 19, 2026 🩺 Medically Reviewed: September 19, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief […]

Low Plateletcrit on CBC: Causes, Clues and Next Steps

カテゴリー
Articles

CBC Interpretation Platelet Health 2026 Update Patient-Friendly A low PCT blood test result usually reflects fewer platelets, smaller platelets, or an analyzer issue—not a diagnosis by itself. The platelet count, MPV, IPF, smear comments, and bleeding history determine whether it matters. 📖 ~11 minutes 📅 September 19, 2026 📝 Published: September 19, 2026 🩺 Medically Reviewed: September 19, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas […]

High Copeptin Level: Meaning, Causes and Test Results

カテゴリー
Articles

Endocrinology Lab Interpretation 2026 Update Patient-Friendly A high copeptin result usually reflects vasopressin-system activation from dehydration, physical stress, or illness—not a diagnosis by itself. Its real value comes from reading it beside sodium, serum osmolality, urine osmolality, and collection conditions. 📖 ~11 minutes 📅 September 19, 2026 📝 Published: September 19, 2026 🩺 Medically Reviewed: September 19, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein […]

Anti-Centromere Antibody: Scleroderma Clues and Limits

カテゴリー
Articles

Autoimmune Testing Lab Interpretation 2026 Update Patient-Friendly An anti-centromere antibody result can be a meaningful clue to limited systemic sclerosis, particularly with Raynaud’s and a centromere ANA pattern. It is not, by itself, a diagnosis or a forecast of how someone will feel. 📖 ~11 minutes 📅 September 19, 2026 📝 Published: September 19, 2026 🩺 Medically Reviewed: September 19, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI […]

Polychromasia on a Blood Smear: Meaning and Next Steps

カテゴリー
Articles

Hematology Lab Interpretation 2026 Update Patient-Friendly Polychromasia on a blood smear means that unusually visible young red cells are circulating. It can be a reassuring sign of marrow recovery after blood loss or treatment, but anemia plus polychromasia should prompt a reticulocyte count and, when indicated, testing for hemolysis. 📖 ~11 minutes 📅 September 18, 2026 📝 Published: September 18, 2026 🩺 Medically Reviewed: September 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, […]

Mold Exposure Blood Tests: What They Can and Cannot Diagnose

カテゴリー
Articles

Indoor Air Health Lab Interpretation 2026 Update Evidence-First A damp building can worsen respiratory health, but no single blood test proves that a particular indoor mold caused your symptoms. The useful test depends on whether the clinical question is allergy, invasive fungal infection, or another illness entirely. 📖 ~11 minutes 📅 September 18, 2026 📝 Published: September 18, 2026 🩺 Medically Reviewed: September 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief […]

HE4 Test Results: High Levels, Kidney Effects and Limits

カテゴリー
Articles

Women’s Health Lab Interpretation 2026 Update Patient-Friendly A high HE4 result deserves careful follow-up, not an automatic cancer conclusion. The number only becomes useful when read alongside kidney function, menopausal status, imaging and the reason the test was ordered. 📖 ~11 minutes 📅 September 18, 2026 📝 Published: September 18, 2026 🩺 Medically Reviewed: September 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is […]

CA 72-4 High: Meaning, Limits and Next Steps for Patients

カテゴリー
Articles

Tumor Marker Lab Interpretation 2026 Update Patient-Friendly A high CA 72-4 result is not a cancer diagnosis. It is a non-specific marker best used as one piece of follow-up information after a known diagnosis, alongside symptoms, imaging, pathology, and changes over time. 📖 ~11 minutes 📅 September 18, 2026 📝 Published: September 18, 2026 🩺 Medically Reviewed: September 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. […]

Macroprolactin Test: When High Prolactin Misleads

カテゴリー
Articles

Endocrinology Lab Interpretation 2026 Update Patient-Friendly A raised prolactin result can reflect a large, mostly inactive hormone-antibody complex rather than excess active prolactin. The distinction can spare patients anxiety, repeat scans, and inappropriate treatment. 📖 ~11 minutes 📅 September 18, 2026 📝 Published: September 18, 2026 🩺 Medically Reviewed: September 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and […]